With this funding, Mumbai-based Neodocs aims to double down its investments in existing products, particularly focusing on its kidney care and urinary tract infections (UTI) kit. It also plans to enhance its self-diagnosis offerings by introducing a finger-prick blood test product that will provide results on a smartphone.